Literature DB >> 29501770

Querectin improves myelin repair of optic chiasm in lyolecithin-induced focal demyelination model.

Reza Naeimi1, Saeideh Baradaran1, Manouchehr Ashrafpour2, Ali Akbar Moghadamnia3, Maryam Ghasemi-Kasman4.   

Abstract

Although the beneficial effects of quercetin on oligodendrocyte precursor cell (OPCs) population has been evaluated in-vitro, there are few studies about the effects of quercetin on myelin repair in the context of demyelination. The aim of this study was to investigate the effects of querectin on functional recovery and myelin repair of optic chiasm in lysolecithin (LPC)-induced demyelination model. Demyelination was induced by local injection of LPC 1% (2 μl) into rat optic chiasm. Querectin at doses 25 or 50 mg/kg was administrated daily by oral gavage for 7 or 14 days post LPC. Visual evoked potential (VEPs) recordings were used to assess the functional property of the optic pathway. Immunostaining and myelin staining were performed on brain sections 7 or 14 days post lesion. Electrophysiological data indicated that LPC injection increased the latency of VEPs waves and quercetin effectively reduced the delay of visual signals. The level of glial activation was alleviated in animals under treatment of quercetin compared to vehicle group. Furthermore, quercetin treatment decreased the extent of demyelination areas and increased the remyelination process following LPC injection. Overall, our findings indicate that quercetin could remarkably improve the functional recovery of the optic pathway by its protective effects on myelin sheath and attenuation of glial activation.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Demyelination; Glial activation; Optic chiasm; Quercetin; Remyelination; Visual evoked potential

Mesh:

Substances:

Year:  2018        PMID: 29501770     DOI: 10.1016/j.biopha.2018.02.125

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset.

Authors:  Berthold Pemp; Karl Kircher; Andreas Reitner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-09-03       Impact factor: 3.117

2.  Co-administration of aspirin and adipose-derived stem cell conditioned medium improves the functional recovery of the optic pathway in a lysolecithin-induced demyelination model.

Authors:  Adel Galeshi; Maryam Ghasemi-Kasman; Farideh Feizi; Nahid Davoodian; Leila Zare; Zeinab Abedian
Journal:  Neuropsychiatr Dis Treat       Date:  2019-09-17       Impact factor: 2.570

3.  Decreased expression of Rev-Erbα in the epileptic foci of temporal lobe epilepsy and activation of Rev-Erbα have anti-inflammatory and neuroprotective effects in the pilocarpine model.

Authors:  Jiong Yue; Jiaojiang He; Yujia Wei; Kaifeng Shen; Kefu Wu; Xiaolin Yang; Shiyong Liu; Chunqing Zhang; Hui Yang
Journal:  J Neuroinflammation       Date:  2020-01-31       Impact factor: 8.322

Review 4.  An unmet clinical need: roads to remyelination in MS.

Authors:  Peter Göttle; Moritz Förster; Vivien Weyers; Patrick Küry; Konrad Rejdak; Hans-Peter Hartung; David Kremer
Journal:  Neurol Res Pract       Date:  2019-07-08

5.  Study on the Anti-demyelination Mechanism of Bu-Shen-Yi-Sui Capsule in the Central Nervous System Based on Network Pharmacology and Experimental Verification.

Authors:  Zheng Zha; Yi-Jiang Liu; Si-Si Liu; Nan Zhang; Jun-Ling Li; Fang Qi; Liang-Yun Jin; Bing Xue; Tao Yang; Yong-Ping Fan; Hui Zhao; Lei Wang
Journal:  Mediators Inflamm       Date:  2022-07-12       Impact factor: 4.529

Review 6.  Quercetin as a JAK-STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases.

Authors:  Hamidreza Zalpoor; Mohsen Nabi-Afjadi; Razieh Forghaniesfidvajani; Chanour Tavakol; Faranak Farahighasreaboonasr; Farid Pakizeh; Vahid Ghobadi Dana; Farhad Seif
Journal:  Cell Mol Biol Lett       Date:  2022-07-26       Impact factor: 8.702

Review 7.  Benefits of hesperidin in central nervous system disorders: a review.

Authors:  Jeongtae Kim; Myung-Bok Wie; Meejung Ahn; Akane Tanaka; Hiroshi Matsuda; Taekyun Shin
Journal:  Anat Cell Biol       Date:  2019-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.